Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 10 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HPW6
Term | Name | Level | Count |
---|---|---|---|
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0032259 | methylation | 2 | 8 |
GO:0043170 | macromolecule metabolic process | 3 | 8 |
GO:0043412 | macromolecule modification | 4 | 8 |
GO:0043414 | macromolecule methylation | 3 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0008168 | methyltransferase activity | 4 | 12 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 11 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
GO:0008276 | protein methyltransferase activity | 3 | 4 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 4 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.454 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.438 |
CLV_PCSK_KEX2_1 | 216 | 218 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 216 | 218 | PF00082 | 0.528 |
CLV_PCSK_PC7_1 | 212 | 218 | PF00082 | 0.499 |
CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.418 |
CLV_PCSK_SKI1_1 | 30 | 34 | PF00082 | 0.642 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.592 |
CLV_PCSK_SKI1_1 | 410 | 414 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 436 | 440 | PF00082 | 0.472 |
DEG_APCC_DBOX_1 | 216 | 224 | PF00400 | 0.540 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.497 |
DEG_SCF_FBW7_1 | 74 | 80 | PF00400 | 0.510 |
DEG_SPOP_SBC_1 | 46 | 50 | PF00917 | 0.550 |
DOC_CKS1_1 | 74 | 79 | PF01111 | 0.510 |
DOC_CYCLIN_RxL_1 | 155 | 162 | PF00134 | 0.543 |
DOC_CYCLIN_RxL_1 | 212 | 224 | PF00134 | 0.517 |
DOC_CYCLIN_yCln2_LP_2 | 225 | 231 | PF00134 | 0.368 |
DOC_MAPK_gen_1 | 419 | 427 | PF00069 | 0.515 |
DOC_MAPK_gen_1 | 471 | 480 | PF00069 | 0.530 |
DOC_MAPK_MEF2A_6 | 35 | 42 | PF00069 | 0.482 |
DOC_MAPK_MEF2A_6 | 449 | 458 | PF00069 | 0.470 |
DOC_MAPK_MEF2A_6 | 473 | 482 | PF00069 | 0.494 |
DOC_MAPK_NFAT4_5 | 35 | 43 | PF00069 | 0.745 |
DOC_PP2B_LxvP_1 | 40 | 43 | PF13499 | 0.715 |
DOC_PP2B_PxIxI_1 | 451 | 457 | PF00149 | 0.486 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.552 |
DOC_USP7_MATH_1 | 341 | 345 | PF00917 | 0.517 |
DOC_USP7_MATH_1 | 47 | 51 | PF00917 | 0.679 |
DOC_USP7_MATH_2 | 335 | 341 | PF00917 | 0.400 |
DOC_WW_Pin1_4 | 282 | 287 | PF00397 | 0.599 |
DOC_WW_Pin1_4 | 73 | 78 | PF00397 | 0.487 |
LIG_14-3-3_CanoR_1 | 22 | 28 | PF00244 | 0.646 |
LIG_14-3-3_CanoR_1 | 273 | 280 | PF00244 | 0.633 |
LIG_14-3-3_CanoR_1 | 30 | 39 | PF00244 | 0.694 |
LIG_14-3-3_CanoR_1 | 338 | 346 | PF00244 | 0.520 |
LIG_14-3-3_CanoR_1 | 362 | 371 | PF00244 | 0.458 |
LIG_14-3-3_CanoR_1 | 44 | 53 | PF00244 | 0.576 |
LIG_14-3-3_CanoR_1 | 56 | 63 | PF00244 | 0.657 |
LIG_14-3-3_CanoR_1 | 82 | 87 | PF00244 | 0.771 |
LIG_APCC_ABBA_1 | 478 | 483 | PF00400 | 0.393 |
LIG_BRCT_BRCA1_1 | 234 | 238 | PF00533 | 0.491 |
LIG_BRCT_BRCA1_1 | 343 | 347 | PF00533 | 0.476 |
LIG_deltaCOP1_diTrp_1 | 189 | 196 | PF00928 | 0.378 |
LIG_deltaCOP1_diTrp_1 | 257 | 262 | PF00928 | 0.380 |
LIG_deltaCOP1_diTrp_1 | 54 | 63 | PF00928 | 0.464 |
LIG_EH1_1 | 462 | 470 | PF00400 | 0.515 |
LIG_FHA_1 | 294 | 300 | PF00498 | 0.476 |
LIG_FHA_1 | 307 | 313 | PF00498 | 0.457 |
LIG_FHA_1 | 379 | 385 | PF00498 | 0.517 |
LIG_FHA_1 | 409 | 415 | PF00498 | 0.526 |
LIG_FHA_1 | 46 | 52 | PF00498 | 0.694 |
LIG_FHA_1 | 74 | 80 | PF00498 | 0.555 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.665 |
LIG_FHA_2 | 311 | 317 | PF00498 | 0.530 |
LIG_FHA_2 | 371 | 377 | PF00498 | 0.578 |
LIG_FHA_2 | 403 | 409 | PF00498 | 0.463 |
LIG_LIR_Gen_1 | 337 | 347 | PF02991 | 0.468 |
LIG_LIR_Gen_1 | 381 | 390 | PF02991 | 0.415 |
LIG_LIR_Gen_1 | 421 | 432 | PF02991 | 0.446 |
LIG_LIR_Gen_1 | 472 | 482 | PF02991 | 0.302 |
LIG_LIR_Nem_3 | 260 | 265 | PF02991 | 0.486 |
LIG_LIR_Nem_3 | 344 | 350 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 381 | 385 | PF02991 | 0.363 |
LIG_LIR_Nem_3 | 421 | 427 | PF02991 | 0.448 |
LIG_LIR_Nem_3 | 472 | 478 | PF02991 | 0.403 |
LIG_MYND_1 | 248 | 252 | PF01753 | 0.371 |
LIG_Pex14_1 | 57 | 61 | PF04695 | 0.459 |
LIG_PTB_Apo_2 | 385 | 392 | PF02174 | 0.368 |
LIG_PTB_Phospho_1 | 385 | 391 | PF10480 | 0.366 |
LIG_SH2_CRK | 382 | 386 | PF00017 | 0.508 |
LIG_SH2_PTP2 | 391 | 394 | PF00017 | 0.409 |
LIG_SH2_SRC | 231 | 234 | PF00017 | 0.374 |
LIG_SH2_STAP1 | 382 | 386 | PF00017 | 0.508 |
LIG_SH2_STAT3 | 484 | 487 | PF00017 | 0.460 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.349 |
LIG_SH2_STAT5 | 391 | 394 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 397 | 400 | PF00017 | 0.466 |
LIG_SH2_STAT5 | 424 | 427 | PF00017 | 0.378 |
LIG_SH2_STAT5 | 71 | 74 | PF00017 | 0.665 |
LIG_SH3_3 | 383 | 389 | PF00018 | 0.369 |
LIG_SH3_3 | 40 | 46 | PF00018 | 0.474 |
LIG_SH3_4 | 439 | 446 | PF00018 | 0.329 |
LIG_SUMO_SIM_anti_2 | 313 | 320 | PF11976 | 0.537 |
LIG_TRAF2_1 | 485 | 488 | PF00917 | 0.579 |
LIG_TRAF2_2 | 394 | 399 | PF00917 | 0.439 |
LIG_UBA3_1 | 160 | 168 | PF00899 | 0.537 |
LIG_UBA3_1 | 219 | 227 | PF00899 | 0.279 |
MOD_CDC14_SPxK_1 | 285 | 288 | PF00782 | 0.547 |
MOD_CDK_SPxK_1 | 282 | 288 | PF00069 | 0.595 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.662 |
MOD_CK1_1 | 282 | 288 | PF00069 | 0.550 |
MOD_CK1_1 | 308 | 314 | PF00069 | 0.400 |
MOD_CK1_1 | 73 | 79 | PF00069 | 0.609 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.749 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.603 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.428 |
MOD_CK2_1 | 204 | 210 | PF00069 | 0.599 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.327 |
MOD_CK2_1 | 337 | 343 | PF00069 | 0.571 |
MOD_CK2_1 | 402 | 408 | PF00069 | 0.466 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.715 |
MOD_CMANNOS | 259 | 262 | PF00535 | 0.380 |
MOD_GlcNHglycan | 131 | 134 | PF01048 | 0.692 |
MOD_GlcNHglycan | 174 | 178 | PF01048 | 0.416 |
MOD_GlcNHglycan | 25 | 28 | PF01048 | 0.749 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.555 |
MOD_GlcNHglycan | 339 | 342 | PF01048 | 0.383 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.531 |
MOD_GlcNHglycan | 491 | 494 | PF01048 | 0.329 |
MOD_GSK3_1 | 253 | 260 | PF00069 | 0.395 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.637 |
MOD_GSK3_1 | 271 | 278 | PF00069 | 0.631 |
MOD_GSK3_1 | 306 | 313 | PF00069 | 0.562 |
MOD_GSK3_1 | 337 | 344 | PF00069 | 0.566 |
MOD_GSK3_1 | 370 | 377 | PF00069 | 0.448 |
MOD_GSK3_1 | 402 | 409 | PF00069 | 0.478 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.642 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.697 |
MOD_N-GLC_1 | 278 | 283 | PF02516 | 0.610 |
MOD_N-GLC_1 | 363 | 368 | PF02516 | 0.669 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.697 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.621 |
MOD_NEK2_1 | 469 | 474 | PF00069 | 0.446 |
MOD_NEK2_2 | 370 | 375 | PF00069 | 0.545 |
MOD_NEK2_2 | 47 | 52 | PF00069 | 0.467 |
MOD_NEK2_2 | 77 | 82 | PF00069 | 0.519 |
MOD_PIKK_1 | 232 | 238 | PF00454 | 0.488 |
MOD_PIKK_1 | 30 | 36 | PF00454 | 0.597 |
MOD_PK_1 | 82 | 88 | PF00069 | 0.533 |
MOD_PKA_2 | 204 | 210 | PF00069 | 0.595 |
MOD_PKA_2 | 272 | 278 | PF00069 | 0.605 |
MOD_PKA_2 | 322 | 328 | PF00069 | 0.581 |
MOD_PKA_2 | 337 | 343 | PF00069 | 0.404 |
MOD_PKA_2 | 418 | 424 | PF00069 | 0.502 |
MOD_PKA_2 | 81 | 87 | PF00069 | 0.674 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.697 |
MOD_Plk_2-3 | 204 | 210 | PF00069 | 0.560 |
MOD_Plk_4 | 227 | 233 | PF00069 | 0.444 |
MOD_ProDKin_1 | 282 | 288 | PF00069 | 0.591 |
MOD_ProDKin_1 | 73 | 79 | PF00069 | 0.489 |
TRG_DiLeu_BaLyEn_6 | 245 | 250 | PF01217 | 0.382 |
TRG_ENDOCYTIC_2 | 265 | 268 | PF00928 | 0.518 |
TRG_ENDOCYTIC_2 | 339 | 342 | PF00928 | 0.465 |
TRG_ENDOCYTIC_2 | 382 | 385 | PF00928 | 0.445 |
TRG_ENDOCYTIC_2 | 397 | 400 | PF00928 | 0.336 |
TRG_ENDOCYTIC_2 | 424 | 427 | PF00928 | 0.367 |
TRG_ENDOCYTIC_2 | 71 | 74 | PF00928 | 0.480 |
TRG_ER_diArg_1 | 20 | 23 | PF00400 | 0.704 |
TRG_ER_diArg_1 | 200 | 203 | PF00400 | 0.324 |
TRG_Pf-PMV_PEXEL_1 | 163 | 167 | PF00026 | 0.477 |
TRG_Pf-PMV_PEXEL_1 | 217 | 221 | PF00026 | 0.517 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HXT0 | Leptomonas seymouri | 56% | 100% |
A0A0S4K087 | Bodo saltans | 49% | 100% |
A0A1X0P0C0 | Trypanosomatidae | 50% | 100% |
A0A3R7N4Z4 | Trypanosoma rangeli | 52% | 100% |
A0A3S7XBK9 | Leishmania donovani | 73% | 97% |
A4IDM8 | Leishmania infantum | 72% | 97% |
D0A4B4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9ATN3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 97% |
Q4Q0W5 | Leishmania major | 73% | 100% |
V5DLL0 | Trypanosoma cruzi | 52% | 100% |